1. Beware of False-Positive FDG PET/CT Interpretations for Presacral Recurrent Rectal Cancer

   Pennings, J. P., de Haas, R. J., de Jong, K. P., Dierckx, R. A. J. O. & Kwee, T. C., May-2019, In : Clinical Nuclear Medicine. 44, 5, p. E342-E344 3 p.

   Research output: Contribution to journal › Editorial › Academic › peer-review

2. Does end-of-treatment FDG-PET improve outcomes in follicular lymphoma?

   Adams, H. J. A. & Kwee, T. C., Jan-2019, In : Lancet Oncology. 20, 1, p. E4 1 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

3. Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma

   Verhoeff, S. R., van Es, S. C., Boon, E., van Helden, E., Angus, L., Elias, S. G., Oosting, S. F., Aarntzen, E. H., Brouwers, A. H., Kwee, T. C., Heskamp, S., Hoekstra, O. S., Verheul, H., van der Veldt, A. A. M., de Vries, E. G. E., Boerman, O. C., van der Graaf, W. T. A., Oyen, W. J. G. & van Herpen, C. M. L., 6-Jun-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension

   Kwee, R. M. & Kwee, T. C., Jul-2019, In : European Journal of Radiology. 116, p. 106-115 10 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

5. Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements

   Kahle, X. U., Hovingh, M., Noordzij, W., Seitz, A., Diepstra, A., Visser, L., van den Berg, A., van Meerten, T., Huls, G., Boellaard, R., Kwee, T. C. & Nijland, M., 26-Apr-2019, In : European Radiology. 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (70) »